I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Randomized, placebo‐controlled trial of ADS‐5102 (amantadin..:
Oertel, Wolfgang
;
Eggert, Karla
;
Pahwa, Rajesh
...
qt3645s67n. , 2017
Link:
https://escholarship.org/uc/item/3645s67n
RT Journal T1
Randomized, placebo‐controlled trial of ADS‐5102 (amantadine) extended‐release capsules for levodopa‐induced dyskinesia in Parkinson's disease (EASE LID 3)
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt3645s67n&Exemplar=1&LAN=DE A1 Oertel, Wolfgang A1 Eggert, Karla A1 Pahwa, Rajesh A1 Tanner, Caroline M A1 Hauser, Robert A A1 Trenkwalder, Claudia A1 Ehret, Reinhard A1 Azulay, Jean Philippe A1 Isaacson, Stuart A1 Felt, Larissa A1 Stempien, Mary Jean PB eScholarship, University of California YR 2017 K1 Brain Disorders K1 Clinical Research K1 Parkinson's Disease K1 Neurodegenerative K1 Clinical Trials and Supportive Activities K1 Neurosciences K1 6.1 Pharmaceuticals K1 Evaluation of treatments and therapeutic interventions K1 Adult K1 Aged K1 80 and over K1 Amantadine K1 Antiparkinson Agents K1 Delayed-Action Preparations K1 Double-Blind Method K1 Dyskinesia K1 Drug-Induced K1 Female K1 Humans K1 Levodopa K1 Male K1 Middle Aged K1 Parkinson Disease K1 Retrospective Studies K1 Severity of Illness Index K1 Time Factors K1 Treatment Outcome K1 Unified Dyskinesia Rating Scale K1 levodopa-induced dyskinesia K1 randomized controlled trial K1 Clinical Sciences K1 Human Movement and Sports Sciences K1 Neurology & Neurosurgery JF qt3645s67n LK http://dx.doi.org/https://escholarship.org/uc/item/3645s67n DO https://escholarship.org/uc/item/3645s67n SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)